NEW YORK,  June 6, 2011 /PRNewswire/ — Aeolus
Pharmaceuticals, Inc. (OTCQB: AOLS) today announced that their June
2nd RetailInvestorConferences.com presentation is available for
on-demand viewing.

LINK: www.retailinvestorconferences.com>
Click the red “register/ watch event now” button.

Aeolus Pharmaceuticals’ presentation will be available for 90
days. Investors may download shareholder materials from the
“virtual trade booth” for the next three weeks.

About Aeolus Pharmaceuticals

Aeolus Pharmaceuticals is developing a new class of catalytic
antioxidant compounds that protects healthy tissue from the
damaging effects of radiation. Its first compound, AEOL 10150, is
being developed for oncology indications, where it is used in
combination with radiation therapy. It is also being developed,
with up to $140 million in funding by the US Government, as a
medical countermeasure against chemical and radiological weapons,
where its initial target indications are as a protective agent
against the effects of acute radiation syndrome and delayed effects
of acute radiation exposure. Aeolus’ strategy is to leverage the
substantial investment in toxicology, manufacturing, and
preclinical and clinical studies made by US Government agencies in
AEOL 10150 to efficiently develop the compound for use in
oncology.

About RetailInvestorConferences.com:

RetailInvestorConferences.com, created by BetterInvesting
(NAIC),PR Newswire and MUNCmedia, is the first
monthly virtual investor conference series that provides an
interactive forum for presenting companies to meet directly with
retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of locatio

‘/>”/>

SOURCE